Skip to main content
. 2016 Sep 12;36(11):1461–1473. doi: 10.1038/onc.2016.304

Figure 3.

Figure 3

Currently tested pharmaceuticals targeting the Wnt pathway in cancer. Schematic representation of the canonical Wnt signaling pathway with pharmaceutical modulators. All depicted drugs are currently undergoing testing in Phase 1/2 against various types of cancer (see also Table 1).